One Health Group plc

("One Health", the "Company" or the "Group")

Director share purchase

One Health Group plc (AIM: OHGR), the independent provider of NHS-funded surgical procedures for patients referred from the NHS through 'Patient Choice', announces that on 21 July 2026, Zak McMurray, Non-Executive Director, purchased 39,840 ordinary shares of 0.5 pence each in the Company ("Ordinary Shares") at a price of 251 pence per Ordinary Share.

Consequently, Mr McMurray's total beneficial interest in the Company is now 53,173 Ordinary Shares, representing approximately 0.38% of the Company's issued share capital.

If you wish to keep up to date on Company news please email: [email protected]

For more information, please contact:

About One Health Group plc (www.onehealth.co.uk)

One Health engages 88 NHS Consultants (excluding anaesthetists) who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and in the year to March 2026 provided much needed care to almost 19,000 new patients, through over 50,000 consultations and over 8,000 surgical procedures. One Health deploys surgeons and anaesthetists that are mostly employed by the NHS, on a subcontracted basis. It currently works with over 140 professionals across 14 independent hospitals and 40 outreach clinics. Within these community-based outreach clinics all consultations and post-operative physiotherapy is delivered where required, reducing patient inconvenience, excess travel and distress.

One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. Currently, the Company's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is derived from 29 ICBs across England as well as contracts with local NHS trusts to transfer their internal waiting list patients to One Health for quicker treatment.

One Health's business model has focused to date on four main areas: orthopaedics, spine, general surgery and gynaecology, which represent the majority of the national waiting list, with urology introduced at the end of FY25.

Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.

Online investor presentation

Click below for the latest online presentation by Derek Bickerstaff, Chairman and Adam Binns, Chief Executive Officer, which offers insights into the Company's financial results for the year ended 31 March 2026, growth strategy and long-term vision: https://www.investormeetcompany.com/meetings/investor-presentation-1068

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM